Bank Pictet & Cie Europe AG lowered its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 81.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 81,587 shares of the company’s stock after selling 359,516 shares during the quarter. Bank Pictet & Cie Europe AG’s holdings in Procter & Gamble were worth $11,692,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Halbert Hargrove Global Advisors LLC bought a new position in Procter & Gamble during the third quarter valued at approximately $25,000. Saranac Partners Ltd bought a new stake in Procter & Gamble in the 3rd quarter worth approximately $30,000. Corundum Trust Company INC purchased a new stake in shares of Procter & Gamble during the 3rd quarter worth approximately $32,000. Caitlin John LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at approximately $34,000. Finally, Marquette Asset Management LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at approximately $37,000. Institutional investors own 65.77% of the company’s stock.
Key Headlines Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Investors are rotating into defensive, dividend-rich consumer staples as recession odds rise, which supports demand for PG stock as a low-beta hedge. As Recession Odds Climb, Defensive Sectors Continue to Outperform (PG)
- Positive Sentiment: New OLAY peptide research was presented at a dermatology conference and P&G plans to integrate proprietary peptide technologies into product formulas—an R&D catalyst that could support premium pricing and brand value over time. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
- Positive Sentiment: Recent session saw PG outperform the market on a prior close, reflecting investor preference for staples amid broader weakness. This shows defensive demand can provide near-term support. Procter & Gamble (PG) Ascends While Market Falls
- Neutral Sentiment: Analysts expect P&G’s upcoming fiscal Q3 results to show low single-digit EPS growth—this raises the bar modestly: a beat could lift the stock, while a slight miss may reinforce current caution. What to Expect From Procter & Gamble’s Next Quarterly Earnings Report
- Neutral Sentiment: Market commentary and analyst notes on consumer goods (including P&G and peers) are circulating, offering mixed takes that could influence near-term analyst revisions but contain no single decisive catalyst. Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG) and Costco (COST)
- Negative Sentiment: TD Cowen cut its price target to $142 from $156 and kept a Hold rating, citing oil-related input-cost inflation tied to geopolitical tensions—this analyst action puts downward pressure on sentiment and could limit near-term upside. TD Cowen Adjusts Price Target on Procter & Gamble to $142 from $156; Maintains Hold Rating
- Negative Sentiment: Reports say Deutsche Bank has lowered expectations for P&G, and coverage notes broadly point to cost pressures (including oil-related input inflation from Middle East tensions) that could compress margins if raw-material costs accelerate. Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price
- Negative Sentiment: Coverage summarizing analyst downgrades highlights Iran-war related cost risks and has contributed to recent negative headlines and downgrades that weigh on sentiment. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More
Analysts Set New Price Targets
Read Our Latest Research Report on Procter & Gamble
Procter & Gamble Stock Performance
NYSE:PG opened at $144.19 on Thursday. The firm has a market capitalization of $335.10 billion, a PE ratio of 21.36, a PEG ratio of 5.08 and a beta of 0.41. The stock’s fifty day moving average is $153.85 and its 200 day moving average is $149.84. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $174.80. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Friday, January 23rd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company had revenue of $22.21 billion during the quarter, compared to analyst estimates of $22.36 billion. During the same period in the previous year, the firm earned $1.88 earnings per share. Procter & Gamble’s quarterly revenue was up 1.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.9%. The ex-dividend date was Friday, January 23rd. Procter & Gamble’s dividend payout ratio is presently 62.67%.
Insider Activity at Procter & Gamble
In related news, insider Balaji Purushothaman sold 12,827 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total value of $2,056,296.37. Following the sale, the insider directly owned 12,639 shares of the company’s stock, valued at $2,026,158.09. This represents a 50.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Chairman Jon R. Moeller sold 162,232 shares of the firm’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the sale, the chairman directly owned 319,385 shares of the company’s stock, valued at approximately $51,884,093.25. The trade was a 33.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 348,618 shares of company stock worth $55,462,643 in the last three months. 0.20% of the stock is owned by insiders.
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
